Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 3
2022 1
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Update on classification of oncocytic neoplasms of the kidney.
Oszwald A, Wasinger G, Zisser L, Compérat E. Oszwald A, et al. Among authors: zisser l. Curr Opin Urol. 2023 May 1;33(3):239-244. doi: 10.1097/MOU.0000000000001079. Epub 2023 Jan 20. Curr Opin Urol. 2023. PMID: 36660966 Review.
Excretion of glucose analogue with SGLT2 affinity predicts response effectiveness to sodium glucose transporter 2 inhibitors in patients with type 2 diabetes mellitus.
Geist BK, Brath H, Zisser L, Yu J, Fueger B, Nics L, Patronas EM, Kautzky-Willer A, Hacker M, Rasul S. Geist BK, et al. Among authors: zisser l. Eur J Nucl Med Mol Imaging. 2023 Aug;50(10):3034-3041. doi: 10.1007/s00259-023-06256-7. Epub 2023 May 17. Eur J Nucl Med Mol Imaging. 2023. PMID: 37195445 Free PMC article.
Response to [ 177 Lu]Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer patients presenting with only lymph node metastases.
Zisser L, Yu J, Oszwald A, Wollenweber T, Kretschmer-Chott E, Grubmüller B, Kramer G, Shariat SF, Mitterhauser M, Vraka C, Hacker M, Haug AR, Rasul S. Zisser L, et al. Nucl Med Commun. 2022 Nov 1;43(11):1113-1120. doi: 10.1097/MNM.0000000000001611. Epub 2022 Sep 19. Nucl Med Commun. 2022. PMID: 36120814 Free PMC article.
Response and Toxicity to the Second Course of 3 Cycles of 177Lu-PSMA Therapy Every 4 Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer.
Rasul S, Wollenweber T, Zisser L, Kretschmer-Chott E, Grubmüller B, Kramer G, Shariat SF, Eidherr H, Mitterhauser M, Vraka C, Langsteger W, Hacker M, Haug AR. Rasul S, et al. Among authors: zisser l. Cancers (Basel). 2021 May 20;13(10):2489. doi: 10.3390/cancers13102489. Cancers (Basel). 2021. PMID: 34065303 Free PMC article.
Renal and Salivary Gland Functions after Three Cycles of PSMA-617 Therapy Every Four Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer.
Wollenweber T, Zisser L, Kretschmer-Chott E, Weber M, Grubmüller B, Kramer G, Shariat SF, Mitterhauser M, Schmitl S, Vraka C, Haug AR, Hacker M, Hartenbach M, Rasul S. Wollenweber T, et al. Among authors: zisser l. Curr Oncol. 2021 Sep 23;28(5):3692-3704. doi: 10.3390/curroncol28050315. Curr Oncol. 2021. PMID: 34590608 Free PMC article.
Induction of Arterial Inflammation by Immune Checkpoint Inhibitor Therapy in Lung Cancer Patients as Measured by 2-[18F]FDG Positron Emission Tomography/Computed Tomography Depends on Pre-Existing Vascular Inflammation.
Calabretta R, Beer L, Prosch H, Kifjak D, Zisser L, Binder P, Grünert S, Langsteger W, Li X, Hacker M. Calabretta R, et al. Among authors: zisser l. Life (Basel). 2024 Jan 19;14(1):146. doi: 10.3390/life14010146. Life (Basel). 2024. PMID: 38276275 Free PMC article.